Nonalcoholic fatty liver disease (NAFLD) in children

Current Opinion in Pediatrics

Volumn 14, Issue 5, 2002, Pages 593-600

  Sathya, Pushpa ^a   Martin, Steven ^a   Alvarez, Fernando ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; AMINOTRANSFERASE; ANTIBIOTIC AGENT; CLOFIBRATE; LIVER ENZYME; METFORMIN; URSODEOXYCHOLIC ACID;

CLINICAL FEATURE; CLINICAL TRIAL; DIABETES MELLITUS; DIET THERAPY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; ENZYME BLOOD LEVEL; EXERCISE; FINANCIAL MANAGEMENT; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; HYPOBETALIPOPROTEINEMIA; INSULIN RESISTANCE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FATTY DEGENERATION; LIVER FIBROSIS; LIVER INJURY; LIVER TOXICITY; LIVER TRANSPLANTATION; MALNUTRITION; OBESITY; PATHOGENESIS; PHLEBOTOMY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; ULTRASOUND; WEIGHT REDUCTION;

ADOLESCENT; AGE FACTORS; CHILD; FATTY LIVER; FEMALE; HUMANS; MALE;

EID: 0036784467     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-200210000-00006     Document Type: Review

References (69)

1. Non-alcoholic fatty liver disease: A spectrum of clinical and pathologic severity
2. Fatty liver. A study of 270 patients with biopsy proven fatty liver and review of the literature
3. Non alcoholic steatohepatitis: Mayo clinic experiences with a hitherto unnamed disease
4. Non alcoholic steatohepatitis
5. Steatohepatitis in obese children: A cause of chronic liver dysfunction
6. Idiopathic steatohepatitis in childhood: A multicenter retrospective study
7. Epidemic of obesity in UK children
8. Overweight and obesity in the US: Prevalence and trends, 1960-1994
9. Independent risk factors of liver fibrosis in patients with nonalcoholic steatohepatitis
10. The chronic disease of childhood obesity: The sleeping giant has awakened
11. Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents
12. Secular trends in the body mass index of Canadian children
13. Non-alcoholic fatty liver disease in an area of southern Italy: Main clinical, histologic, and pathophysiologic aspects
14. Prevalence of fatty liver in Japanese children and relation to obesity: An epidemiological Ultrasonographic survey
15. The relation between fatty liver and hyperinsulinemia in obese Japanese children
16. Establishing a standard definition for child overweight and obesity worldwide: International survey
17. Body mass index as a measure of adiposity among children and adolescents: A validation study
18. Guidelines for overweight in adolescent preventive services: Recommendations from an expert committee
19. 2) and triceps skin fold thickness
20. Percentiles for BMI in U.S. children 5-17 years of age
21. Establishing a standard definition for child overweight and obesity worldwide: International survey
22. Serum alanine aminotransferase activity in obese children
23. AST/ALT ratio predicts cirrhosis in patients with chronic Hep C virus infection
24. Liver involvement in obese children. Ultrasonagraphy and liver enzyme levels at diagnosis and during follow-up in an Italian population
25. Noninvasive in vivo quantitative assessment of fat content in human liver
26. Non-alcoholic steatohepatitis: An expanded clinical entity
27. Non-alcoholic steatohepatitis: Tightening the morphologic screws on a hepatic rambler
28. Mitochondrial abnormalities in nonalcoholic steatohepatitis
29. Fatty liver in heterozygous hypobetalipoproteinemia caused by a novel truncated form of apolipoprotein B
30. Acute steatosis in an 8-year-old boy with insulin dependent diabetes mellitus
31. Steatohepatitis: A tale of two hits?
32. Non alcoholic steatohepatitis (NASH): A disease of emerging identity and importance
33. Nonalcoholic steatohepatitis in children
34. Lipids upregulate uncoupling protein 2 expression in rat hepatocytes
35. Hepatic steatosis: Innocent bystander or guilty party?
36. Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity
37. Therapeutic controversy obesity - A modern day epidemic
38. Leptin, obesity and liver disease
39. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: Further evidence for an etiologic association
40. Persistent hyperaminotransferasemia resolving after weight reduction in obese children
41. Increased hepatic iron stores in non-alcoholic steatohepatitis is associated with increased hepatic fibrosis
42. Non-alcoholic steatohepatitis
43. Non-alcoholic steatohepatitis: Clinical significance and pathogenesis
44. Association of non alcoholic fatty liver disease with insulin resistance
45. NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome
46. Nonalcoholic fatty liver disease: Predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese
47. The natural history of nonalcoholic fatty liver: A follow-up study
48. NASH in obesity, a reversible condition
49. The natural history of nonalcoholic steatohepatitis: A follow-up study of 42 patients for up to 21 years
50. Overweight is risking fate
51. Drug therapy for obesity - A therapeutic option?
52. Fatty liver and its fibrous changes found in simple obesity of children
53. Therapeutic effects of restricted diet and exercise in obese patients with fatty liver
54. Effect of weight reduction on serum transaminase activities in children with simple obesity
55. Effect of weight reduction on hepatic abnormalities in overweight patients
56. Metabolic changes associated with obesity before and after weight reduction
57. Fasting in obesity: Another cause of liver injury with alcoholic hyaline?
58. Obesity: A cause of steatohepatitis in children
59. Ursodeoxycholic acid or clofibrate in the treatment of nonalcohol induced steatohepatitis: A pilot study
60. Lack of efficacy of ursodeoxycholic acid for the treatment of liver abnormalities in obese children
61. Comparison of serum concentrations of α-tocopherol and β-carotene in a cross sectional sample of obese and non-obese children (NHANES III)
62. Vitamin E treatment of nonalcoholic steatohepatitis in children: A pilot study
63. Metformin in non-alcoholic steatohepatitis
64. Metformin in non-alcoholic steatohepatitis
65. Recurrence of nonalcoholic steatohepatitis following liver transplantation
66. Liver transplantation for non-alcoholic steatohepatitis
67. Non-alcoholic steatohepatitis
68. Evidence based management of childhood obesity
69. Recent advances: Pediatrics